Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas

Abstract
Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs. WW domain-containing oxidored